Sinopsis
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
Episodios
-
![Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients]()
Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients
22/07/2020 Duración: 02minC. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.
-
![Episode 98: #WomenAs1: The Battle for Gender Equality]()
Episode 98: #WomenAs1: The Battle for Gender Equality
15/07/2020 Duración: 06minRoxana Mehran brings C. Michael Gibson up to speed on a campaign to promote talent in medicine by offering professional opportunities to female physicians.
-
![Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin]()
Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin
02/07/2020 Duración: 04minUsman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.
-
![Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI]()
Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI
17/06/2020 Duración: 05minC. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.
-
![Episode 95: FORZA: Randomized Trial of Fractional Flow Reserve]()
Episode 95: FORZA: Randomized Trial of Fractional Flow Reserve
20/05/2020 Duración: 05minWhat are the respective values of FFR and OCT in guiding revascularization? C. Michael Gibson gets a primer from Francesco Burzotta.
-
![Episode 94: Wearables - The Future Is Now]()
Episode 94: Wearables - The Future Is Now
22/04/2020 Duración: 06minC. Michael Gibson connects with Sameer Mehta and Francisco Fernandez to hear how new tech is poised to disrupt medical care.
-
![Episode 93: Onyx ONE]()
Episode 93: Onyx ONE
17/04/2020 Duración: 07minC. Michael Gibson learns about the Onyx ONE trial from Stephan Windecker.
-
![Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin]()
Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin
01/04/2020 Duración: 05minC. Michael Gibson reviews the randomized TWILIGHT trial results with Roxana Mehran.
-
![Episode 91: Propensity Score-Matched Analysis]()
Episode 91: Propensity Score-Matched Analysis
18/03/2020 Duración: 04minMaurizio Taramasso walks C. Michael Gibson through randomized data focused on tricuspid valve disease.
-
![Episode 90: MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk]()
Episode 90: MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk
04/03/2020 Duración: 03minC. Michael Gibson hears from Ken Kozuma about the single-arm MODEL U-SES study.
-
![Episode 89: STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the US]()
Episode 89: STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the US
24/02/2020 Duración: 08minVinay Badhwar discusses new data from the STS Registry addressing volume/outcome relationships for mitral valve surgery.
-
![Episode 86: REMEDIAL III: Urine Flow Rate-Guided vs LVEDP-Guided Hydration]()
Episode 86: REMEDIAL III: Urine Flow Rate-Guided vs LVEDP-Guided Hydration
16/01/2020 Duración: 04minC. Michael Gibsons sits down with Carlo Briguori to discuss the REMEDIAL III trial results.
-
![Episode 85: REDUCE-FMR: Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation]()
Episode 85: REDUCE-FMR: Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation
07/01/2020 Duración: 06minSamir Kapadia, Horst Sievert, and C. Michael Gibson discuss this randomized sham-controlled trial of the Carillon device.
-
![Episode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI]()
Episode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI
18/12/2019 Duración: 07minC. Michael Gibson and Dean Kereiakes discuss the first human use of RUC-4, designed for STEMI point-of-care treatment.
-
![Episode 83: The Medically Ill Patients in AUGUSTUS]()
Episode 83: The Medically Ill Patients in AUGUSTUS
04/12/2019 Duración: 03minC. Michael Gibson discusses the AUGUSTUS trial with Renato Lopes.
-
![Episode 82: EXCEL: 5-Year Outcomes]()
Episode 82: EXCEL: 5-Year Outcomes
20/11/2019 Duración: 09minC. Michael Gibson speaks with Gregg Stone about EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease.
-
![Episode 81: COAPT 3-Year Outcomes]()
Episode 81: COAPT 3-Year Outcomes
06/11/2019 Duración: 04minC. Michael Gibson speaks with Michael Mack about the COAPT Trial 3-year outcomes and results.
-
![Episode 80: PARTNER 3 Low-Risk Computed Tomography Substudy]()
Episode 80: PARTNER 3 Low-Risk Computed Tomography Substudy
25/10/2019 Duración: 05minC. Michael Gibson speaks with Raj Makkar about PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves
-
![Episode 79: LEVANT: 5-Year Outcomes From Three Randomized Trials]()
Episode 79: LEVANT: 5-Year Outcomes From Three Randomized Trials
16/10/2019 Duración: 04minC. Michael Gibson speaks with Kenneth Ouriel about LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease
-
![Episode 78: REDUCE-FMR: A Sham-Controlled Randomized Trial]()
Episode 78: REDUCE-FMR: A Sham-Controlled Randomized Trial
18/09/2019 Duración: 02minC. Michael Gibson sits down with Horst Sievert to learn more about the REDUCE-FMR trial.
